Clal Insurance Enterprises Holdings

Clal Insurance Enterprises Holdings provides insurance and financial services in Israel. The company’s Long-term Savings segment offers insurance covering various risks, such as life, death, disability, loss of work capacity, and health, as well as provides pension and provident funds. Its Health Insurance segment provides long term care, medical expense, surgeries, transplants, personal accidents, travel, dental, foreign workers, and other insurance services. The company’s Non-Life Insurance segment offers liability and property, credit, personal accident, and other insurance services. Its Other segment engages in the credit and financing activities; and insurance agency operations. The company primarily offers its products and services for individuals, policyholders, self-employed workers, and collectives. Clal Insurance Enterprises Holdings Ltd. was founded in 1987 and is based in Tel Aviv, Israel.

Yoram Naveh

CEO

12 past transactions

Pyramid Analytics

Series E in 2022
Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Learn more www.pyramidanalytics.com

Shopic

Series B in 2022
Shopic provides a Frictionless Shopping experience for medium and large grocery stores.

MeMed

Venture Round in 2022
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse. Antibiotics are the most prescribed class of drugs worldwide with a global market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system. ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases.

Bluewhite

Series B in 2021
Blue White Robotics revolutionizes agriculture through autonomy. We provide a complete infrastructure for autonomy and in-field data for improving productivity and farm economics. Our platform transforms existing fleets into autonomous, manages, and optimizes them both air & ground while collecting and distributing data seamlessly. We improve efficiency, and safety and provide actionable insights that drive ROI from the first day. Leveraging remote sensing and AI, we are setting the highest standard for easy and safe adoption of autonomy in agriculture today. Autonomy, Now.

Silk

Series B in 2021
Silk's Cloud Data Platform enhances cloud efficiency by optimizing performance and reducing costs for organizations. It allows businesses to achieve up to ten times the performance from their existing cloud data while simultaneously decreasing expenditures by 30%. The platform integrates seamlessly between the application stack and cloud infrastructure, ensuring that operations run more effectively without requiring any changes to existing systems. Key features include real-time data reduction, thin provisioning, and continuous resource optimization, which collectively ensure that cloud spending aligns with actual data requirements at all times. This innovative approach enables organizations to maximize their cloud capabilities while minimizing unnecessary costs.

IRP Systems

Series C in 2021
IRP makes electric vehicles powerful and affordable. By leveraging its breakthrough technology in control algorithms and powertrain design, its systems reach an unprecedented level of efficiency, in full compliance with mass-production practices. TrueDrive, IRP's wide portfolio of innovative products, offers high performance, a unique driving experience and advanced functionality, while being cost-effective. Before focusing on e-mobility, IRP has developed, certified and delivered motion systems for safety-critical aerospace applications.

Pagaya

Series D in 2020
Pagaya Investments (Pagaya) is a financial technology company reshaping the asset management space using machine learning and big data analytics to manage institutional money. With a focus on fixed income and alternative credit, Pagaya offers a variety of discretionary funds to institutional investors including pension funds, insurance companies, and banks. Pagaya’s unique technology platform — Pagaya Pulse — runs on a suite of artificial intelligence technologies and state-of-the-art algorithms to deliver a consistently high and scalable performance edge.

Pagaya

Series C in 2019
Pagaya Investments (Pagaya) is a financial technology company reshaping the asset management space using machine learning and big data analytics to manage institutional money. With a focus on fixed income and alternative credit, Pagaya offers a variety of discretionary funds to institutional investors including pension funds, insurance companies, and banks. Pagaya’s unique technology platform — Pagaya Pulse — runs on a suite of artificial intelligence technologies and state-of-the-art algorithms to deliver a consistently high and scalable performance edge.

MeMed

Series C in 2018
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse. Antibiotics are the most prescribed class of drugs worldwide with a global market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system. ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases.

Pagaya

Series B in 2018
Pagaya Investments (Pagaya) is a financial technology company reshaping the asset management space using machine learning and big data analytics to manage institutional money. With a focus on fixed income and alternative credit, Pagaya offers a variety of discretionary funds to institutional investors including pension funds, insurance companies, and banks. Pagaya’s unique technology platform — Pagaya Pulse — runs on a suite of artificial intelligence technologies and state-of-the-art algorithms to deliver a consistently high and scalable performance edge.

OrCam Technologies

Venture Round in 2018
OrCam harnesses the power of artificial vision in an intuitive portable device that compensates for lost visual abilities. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people with vision loss. The OrCam device is a smart camera mounted on the frames of your eyeglasses, which “sees” text, recognizes objects and “whispers” in your ear.

Carr Properties

Debt Financing in 2018
Carr Properties is a privately held real estate investment trust focused on creating value for its shareholders through the ownership, acquisition and development of high-quality office properties in the greater Washington area. The company maintains ownership of 16 commercial office properties totaling over 3.6 million square feet as well as three major development properties – Midtown Center in Washington, DC (previously known as the Washington Post Site); 2311 Wilson Boulevard in Arlington, Virginia; and 2025 Clarendon Boulevard in Arlington, Virginia. Upon completion, these projects will add an additional 1.25 million square feet of trophy-quality office space to the company’s portfolio. The company is continuing to expand its portfolio through strategic investments in the Washington area.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.